The pathogenesis of cingulate atrophy in behavioral variant frontotemporal dementia and Alzheimer’s disease by Rachel H Tan et al.
Tan et al. Acta Neuropathologica Communications 2013, 1:30
http://www.actaneurocomms.org/content/1/1/30RESEARCH Open AccessThe pathogenesis of cingulate atrophy in
behavioral variant frontotemporal dementia and
Alzheimer’s disease
Rachel H Tan1, Karen Pok2, Stephanie Wong1, Daniel Brooks1,3, Glenda M Halliday1,3 and Jillian J Kril2,4*Abstract
Background: Early atrophy of the cingulate cortex is a feature of both behavioral variant frontotemporal dementia
(bvFTD) and Alzheimer’s disease (AD), with degeneration of the anterior cingulate region increasingly recognized as
a strong predictor of bvFTD. The total number of neurons in this region, rather than the density of neurons, is
associated with mood disturbance in other dementias, although there are no data on the extent and magnitude of
neuronal loss in patients with bvFTD. While the density of small populations of neurons in this region has been
assessed, it is unlikely that the degree of atrophy of the cingulate cortex seen in bvFTD can be explained by the
loss of these subpopulations. This suggests that there is more generalized degeneration of neurons in this region in
bvFTD.
The present study assesses total neuronal number, as well as characteristic pathologies, in the anterior and posterior
cingulate cortices of pathologically confirmed bvFTD (N = 11) and AD (N = 9) patients compared with age-matched
controls (N = 14). The bvFTD cohort comprised 5 cases with tau pathology (Pick’s disease), and 6 with TDP-43
pathology.
Results: At postmortem, atrophy was detected in the anterior and posterior cingulate cortices of bvFTD cases, but
only in the posterior cingulate cortex of AD cases. As predicted, there was a significant reduction in both the
density and total number of neurons in the anterior but not the posterior cingulate cortex of bvFTD cases with the
opposite observed for the AD cases. Importantly, neuronal loss in the anterior cingulate cortex was only observed
in cases with tau pathology.
Conclusions: This study confirms significant neuronal loss in the posterior but not anterior cingulate cortex in AD,
and demonstrates that significant neuron loss in bvFTD occurs only in the anterior cingulate cortex but only in
cases with tau pathology compared with cases with TDP pathology. We propose that significant
neurodegeneration in the anterior cingulate cortex may be useful in differentiating the pathological subtypes
in vivo.
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Table 1 Group demographics and pathological variables
(standard deviation) for patients with behavioral variant
frontotemporal dementia (bvFTD), Alzheimer’s disease
(AD) and controls
bvFTD AD Control
N (% male) 11 (6) 9 (7) 14 (9)
Mean age at death (year) 67 (9) 73 (5) 73 (10)
Postmortem delay (hour) 9 (12) 14 (10) 24 (12)
Mean age of diagnosis (years) 59 (5) 68 (5) -
Duration of disease (years) 7 (4) 5 (2) -
Clinical dementia rating (0 – 3) 2.2 (0.9) 1.7 (0.9) 0
Tan et al. Acta Neuropathologica Communications 2013, 1:30 Page 2 of 6
http://www.actaneurocomms.org/content/1/1/30Background
Structural and metabolic neuroimaging studies have shown
that the cingulate cortex is one of the earliest affected re-
gions in both the behavioral variant of frontotemporal de-
mentia (bvFTD) and Alzheimer’s disease (AD), with the
seemingly reverse pattern of cingulate involvement poten-
tially helpful in the differentiation of these two dementia
syndromes [1,2]. Atrophy of the anterior cingulate cortex
(AC) is increasingly recognized as a strong predictor of
bvFTD [2,3], and the aberrant social behavior and affective
changes typical of this dementia have been ascribed to the
selective vulnerability of von Economo neurons (VENs)
within this region [4]. However, VENs constitute only 1-2%
of the total neurons in cortical layer 5b in the AC, deeming
it improbable that the selective destruction of these neurons
alone can account for the severe and early atrophy of the
AC observed in bvFTD. Similarly, a loss of VENs has been
reported in AD [5], a dementia in which behavior is rela-
tively preserved until late in the disease. To date, histopatho-
logical analyses of the cingulate cortex in bvFTD and AD
have quantified the density of specific neuronal populations
or laminae [4,6]. There has been no assessment of the entire
neuronal population of the cingulate cortex in either disease.
Furthermore, as there is significant atrophy of the cingulate
cortex in both bvFTD and AD the magnitude of the neur-
onal loss may have been underestimated. The quantification
of total neuron number in cortical regions requires accurate
measurement of the volume of the region [7]. The signifi-
cance of assessing total neuronal loss has been emphasized
in Huntington’s disease, where mood symptomatology asso-
ciates with total neuronal loss, rather than the loss of a spe-
cific neuronal population in the AC [8]. The present study
assesses total neuron numbers in the AC and posterior cin-
gulate cortex (PC) in pathologically confirmed cases of
bvFTD and AD to determine the pathological basis of neu-
roimaging findings observed in these dementias.
Results and discussion
Demographics
The present study was comprised of 11 cases with a clin-
ical and pathological diagnosis of bvFTD (FTLD-TDP:
n = 6; FTLD-tau: n = 5), 9 cases with clinical and patho-
logical AD, and 14 age-matched controls. Although
bvFTD and AD cohorts did not differ in terms of age or
sex distribution (all p values > 0.1) (Table 1), multivariate
analysis demonstrated an interaction between neuronal
loss and age (p < 0.05). Therefore age was included as a
covariate in the analyses.
Volumes
Significant volume loss was observed in AC in cases with
bvFTD compared to controls and AD (p < 0.001,
Figure 1A). In PC, volume loss was significant in both
bvFTD and AD (p < 0.5, Figure 1B). No differences wereobserved in the degree of atrophy between bvFTD cases
with either tau or TDP-43 pathology (p > 0.05, Figure 1).
Assessment of the AC:PC volume ratio revealed a re-
duced ratio for bvFTD cases with tau pathology, no
change in the ratio for bvFTD cases with TDP-43 path-
ology, and an increased ratio in AD cases (Figure 1C).
Neuronal loss
Significant between-group differences in regional neur-
onal densities and estimated neuronal numbers were
identified (p < 0.001), with changes in neuronal density
largely reflecting the degree of degeneration in total
neuronal numbers (Figure 1). In the AC, neuronal loss
was only significant in bvFTD cases compared with both
controls (means ± standard deviation total number of
55,555,584 ± 21,086,167, bvFTD 39 ± 10% of mean con-
trol values, p < 0.05) and AD (74 ± 11% of mean control
values, p = 0.05), with the loss observed only in cases
with FTLD-tau (45% more neuronal loss in AC than
those with FTLD-TDP, p < 0.05, Figure 1A). Despite
similar PC atrophy in all groups (Figure 1B), only cases
with AD had significant neuronal loss compared with
controls (mean total number of 46,684,395 ± 18,466,349,
Figure 1B). There were no significant differences be-
tween the PC neuronal number in the bvFTD subgroups
(p > 0.05, Figure 1B). Assessment of the AC:PC neuronal
number ratio revealed a more significantly reduced ratio
for bvFTD cases with tau pathology, no change in the
ratio for bvFTD cases with TDP-43 pathology, and a
more significantly increased ratio in AD cases compared
with the volume ratios in the same regions (Figure 1C).
Neuronal pathologies
No pathological deposits were found in the cingulate
cortex of any control. TDP-43-immunoreactivity in
FTLD-TDP cases was sparse in the cingulate cortex des-
pite typical histopathology in the frontal, entorhinal and
temporal cortices of these cases. TDP-43-immunoreac-
tive inclusions consisted of small, dense and rounded
neuronal cytoplasmic inclusions (Figure 2C). TDP-43-
immunoreactive dystrophic neurites were mostly short
Figure 1 Degeneration of the anterior and posterior cingulate
cortex in AD and bvFTD. Mean volume, neuron density and total
neuron number (± standard error) in Alzheimer’s disease (AD), FTLD-
tau and FTLD-TDP expressed as a % of mean control values in the
anterior cingulate (A) and posterior cingulate (B). The extent of
degeneration in the anterior cingulate compared to the posterior
cingulate in AD, FTLD-tau and FTLD-TDP is identified as a change
from an equal ratio identified by grey bar at 1.0 (C). *p < 0.05 in
comparison to controls.
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itional long dystrophic neurites. Abnormal tau deposition
as intracellular neurofibrillary tangles and Pick bodies was
observed in the cingulate cortex in all cases with AD and
FTLD-tau, respectively (Figure 2A-B). Tau-immunoreactive
dystrophic neurites were also observed in all AD and FTLD-
tau cases. In FTLD-tau, the density of tau inclusions was
greatest in the AC (mean ± SE of total remaining neurons:
24.5% ± 5.7%) compared to PC (mean ± SE of total
remaining neurons: 2.3% ± 0.6%, p = 0.001). This regional
difference in pathological severity was not observed in either
FTLD-TDP (mean ± SE of total remaining neurons: AC: 19
± 4.4; PC: 24 ± 22) or AD (mean ± SE of total remaining
neurons: AC: 2 ± 0.8; PC: 0.6 ± 1.4). Significant regional dif-
ferences between groups were observed in FTLD-TDP com-
pared to FTLD-tau (p < 0.005) but not AD (p > 0.05).
Pathology correlations
Spearman rank correlations were used to determine any
relationships between the severity of pathological inclu-
sions and the degree of neuronal loss in the AD and
bvFTD sub-groups. These analyses revealed an associ-
ation between the severity of neuronal loss with path-
ology in AD (ρ = −0.614, p = 0.007) and FTLD-tau
(ρ = −0.842, p = 0.002), but not in FTLD-TDP cases.
Clinicopathological correlations
Spearman rank correlations were also used to identify
any relationships between regional neuronal loss or the
percentage of inclusion pathology with disease duration
and last Clinical Dementia Rating score in the AD,
bvFTD and bvFTD subgroups. The severity of patho-
logical inclusions increased with an earlier onset of AD
(ρ = −0.638, p < 0.005). No other associations were
identified.
Discussion
This is the first quantitative analysis of total neuronal
number in the cingulate cortex of bvFTD and AD that
accounts for volumetric changes in this region. The
degree of cingulate atrophy demonstrated in structural
imaging suggests considerable degeneration of neurons
in both dementia groups, which our data supports. How-
ever, direct comparison between patient groups showed
Figure 2 Photomicrographs of the posterior cingulate cortex (PC) in Alzheimer’s disease (AD, A) and the anterior cingulate cortex (AC)
in FTLD-tau (B) and FTLD-TDP (C). Neuronal loss is obvious in these regions, with more severe degeneration observed in FTLD-tau (B), and a
similar extent of degeneration observed in FTLD-TDP (C) and AD (A). Comparable levels of tau-immunopositivity in neurofibrillary tangles
(A, inset) and Pick bodies (B, inset) was observed in PC in AD (A) and in AC in FTLD-tau (B). Sparse numbers of TDP-43 inclusions (C, inset) were
found in cases with FTLD-TDP (C).
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cases with Pick disease pathology, while we can confirm
significant PC neuronal loss occurs in AD [9]. We can
also add that overall neuronal numbers in the PC are
largely spared in pathologically confirmed cases of
bvFTD, despite atrophy of this region by end-stage. Our
data are consistent with previous volumetric data show-
ing atrophy of PC over the course of bvFTD and not at
initial diagnosis across all pathological subtypes [3] or in
cases with later confirmed FTLD-TDP [10,11]. This in-
formation suggests that later PC atrophy in bvFTD most
likely reflects synaptic loss and/or cell shrinkage, as we
did not observe significant total neuronal loss in the
bvFTD cases with PC atrophy.
In bvFTD, neuronal loss in AC was observed only
in cases with FTLD-tau (Pick bodies) compared to
those with FTLD-TDP. This differs from other re-
gional changes where the hippocampus is more af-
fected in patients with FTLD-TDP compared with
FTLD-tau [3], with the suggestion that more severe
episodic memory and hippocampal atrophy may be a
potential biomarker for FTLD-TDP in vivo. The
present data now show variability in the populations
of neurons vulnerable to tau pathology in bvFTD and
may suggest that greater neuronal loss and atrophy in
AC could reflect underlying FTLD-tau, the presence
of Pick bodies specifically, in in vivo studies. Of sig-
nificance is our previous finding that AC is affected
early in bvFTD while atrophy of PC is a late event
[3]. This suggests that rapid AC atrophy could be
tested as an early biomarker for FTLD-tau, although
this finding would need to be confirmed in other
tauopathies as only Pick disease was included in the
present study.Conclusions
BvFTD is a clinically heterogeneous disorder and corre-
lations between clinical and pathological subtypes have
been weak at best [12]. The need to distinguish between
the underlying pathologies is becoming increasingly ap-
parent with increasing efforts directed towards the de-
velopment of targeted disease-modifying therapies in
FTD. For many years drugs targeting tau protein abnor-
malities have been investigated as a potential treatment
for AD. However, given the occurrence of both tau and
Abeta pathologies in AD, the therapeutic effects of tau-
directed treatments may be less obvious in AD than
when assessed in patients with pure pathology such as
seen in FTLD-tau (see [13] for a review). While future
studies comparing the extent of neurodegeneration
across larger pathological subgroups are necessary, the
present findings suggest that greater atrophy of AC may




Eleven cases with a clinical diagnosis of bvFTD [14] and
FTLD pathology [15], 9 cases with clinical and patho-
logical AD [16], and 14 controls without dementia or
significant neuropathological abnormalities were selected
from a neuropathological series of cases collected by the
Sydney Brain Bank through a regional brain donor pro-
gram. Patients were diagnosed by experienced clinicians
using standard diagnostic criteria [17,18] following a
medical interview and an informant history. The bvFTD
all had changes in personality or social behaviour (eg.
apathy, disinhibition, stereotypic behaviours, alterations
in food preference, or poor self-care) and executive
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or organisation). The program holds approval from the
Human Research Ethics Committee of The University of
New South Wales and complies with the statement on
human experimentation issued by the National Health
and Medical Research Council of Australia. This re-
search project was approved by the Human Research
Ethics Committees of the Universities of Sydney and
New South Wales. Some of the cases included in this
study have been reported in previous publications
[3,19,20]. The research program used standardized tests
following the patients longitudinally with the last assess-
ments performed within 14 months of death. All demen-
tia cases had Clinical Dementia Rating (CDR) scores
between 1 and 3 while controls had scores of <0.5. The
postmortem interval was 16 hours on average (range: 2–
45 h; mean ± SD for bvFTD = 9 ± 12, for AD = 14 ± 10,
and for control = 24 ± 12, ANOVA p > 0.05). Cases with
bvFTD with TDP pathology (FTLD-TDP, n = 6, 5 males;
age range 53–72 years; 2 with type A, 2 with type B and
2 with type C) [21] and tau pathology (FTLD-tau, n = 5,
1 male; age range 65–79 years; 5 with Pick’s disease)
were selected for this study. Cases with all types of TDP-
43 pathologies were selected, as our previous study
showed no differences between different TDP-43 path-
ology types at end-stage [3]. Case details are shown in
Table 1.
Tissue preparation and volume measurements
Tissue preparation and volumetric methods used in this
study have been published in detail elsewhere [19,20].
Briefly, brains were collected at autopsy, fixed in 15% neutral
buffered formalin for two weeks, the fixed brain weighed
and the volume determined by fluid displacement. The cere-
bellum and brainstem were separated from the cerebrum by
sectioning through the cerebral peduncles. Each cerebrum
was embedded in 3% agarose, sectioned in 3 mm coronal
slices using a rotary slicer, photographed and printed at 1×
magnification. The average slice thickness for each brain
was determined by dividing the hemisphere length by the
total number of slices. Diagnostic neuropathological screen-
ing was conducted using standardized blocks taken from
the frontal, parietal, temporal and occipital cortices, amyg-
dala, hippocampus, basal ganglia, diencephalon, midbrain,
pons, medulla oblongata and cerebellum. Examination of
sections stained with haematoxylin and eosin and modified
Bielschowsky silver stain, as well as immunohistochemically
for tau, ubiquitin, α-synuclein and TDP-43, confirmed
pathological diagnoses.
Anatomical structures and gyral boundaries most consist-
ently associated with cytoarchitectonic boundaries were
used to identify the AC and PC for all cases, as previously
described [19,20]. The AC was divided from the PC at the
central lobule of the central sulcus. The volumes of theseregions were determined by a point counting procedure on
the brain slice photographs as previously described [19,20].
Briefly, the areas corresponding to each region were identi-
fied on the brain slice photographs and were randomly over-
laid with a grid of 3848 points (each separated by 4 mm).
The total number of points falling on each region of interest
was counted and the volumes calculated by multiplying the
sum of points falling on a given region by the volume repre-
sented by each point (volume/point = 16 mm2 ×mean slice
thickness; average of 50 mm3). This method is routinely
used in our laboratory to measure regional volumes post-
mortem [20,22,23] and approximates current point counting
procedures used in MRI studies of brain volumes.
Quantitation of neuron numbers and inclusion
pathologies
Standardised tissue samples of the cingulate cortices were
sampled (AC just posterior to the genu of the corpus
collosum, PC just anterior to the splenium of the corpus
callosum) and embedded in paraffin wax using routine pro-
cedures. Ten μm serial sections were cut from each block
and immunohistochemically stained with antibodies to tau
(mouse anti-human tau diluted 1:1000; Thermo Scientific)
and TDP-43 (rabbit anti-human TDP-43 diluted 1:800;
ProteinTech) using routine techniques [3]. An additional
section was stained with cresyl violet (0.5%). Quantitation of
cortical neuronal populations was performed as previously
described and validated [7]. Briefly, 2 × 500 μm wide strips
through the entire cortical thickness from the pial surface to
white matter were randomly sampled by marking perpen-
dicular lines on the coverslip of each slide. Strips were not
selected if the cortex was cut obliquely at the marked line to
ensure even representation of all cortical laminae. Neurons
were counted at 200× magnification using a 10 × 10 eye-
piece graticule (500 μm×500 μm) with standard inclusion
(lower and left) and exclusion (upper and right) borders in
contiguous, non-overlapping fields. The density of neurons
within each region was calculated for each case, and the
total number of neurons estimated by multiplying neuronal
density by the calculated volume for the AC and PC, as ap-
propriate. The percentage of neurons with cytoplasmic in-
clusions in the AC and PC was expressed as a percentage of
total remaining neurons. Quantitation was performed by
two raters blind to case details with an inter-rater variance
of 2.4% and intra-rater variability of 2.2%.
Statistical analysis
Data were analysed using SPSS19.0 (IBM Corp., Chicago,
Ill., USA). Group differences in age and postmortem
delay across all groups were investigated using analysis
of variance (ANOVA), and where these variables showed
significant differences, they were entered as co-variates
in the multivariate ANOVA. Post hoc analyses using the
Bonferroni correction for multiple comparisons were
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gional neuronal loss. Any associations between neuronal
number and the percentage of neurons with pathological
depositions (tau, TDP-43) or measures of disease sever-
ity (disease duration and CDR score) were identified
with Spearman rank correlations.
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